Medicare Enrolled

Dr. Gerardo Polanco, MD

Cardiovascular Disease · Miami, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
8500 SW 92ND ST, Miami, FL 33156
3052793878
In practice since 2006 (19 years)
NPI: 1669415741 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Polanco from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Polanco? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Polanco

Dr. Gerardo Polanco is a cardiovascular disease in Miami, FL, with 19 years in practice. Based on federal Medicare data, Dr. Polanco performed 4,645 Medicare services across 1,596 unique beneficiaries.

Between the years covered by Open Payments, Dr. Polanco received a total of $8,099 from 35 pharmaceutical and/or device companies across 473 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Polanco is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 23% volume in FL$ $8,099 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,645
Medicare services
Top 23% in FL for cardiovascular disease
1,596
Unique beneficiaries
$37
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~244 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)1,200$0$1
Remote patient monitoring management, 20 min/month768$36$105
Electrocardiogram (EKG), 12-lead552$11$31
Remote patient monitoring device, 30 days500$39$110
Office visit, established patient (30-39 min)498$93$270
EKG interpretation and report418$7$87
Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes260$31$91
Echocardiogram, transthoracic97$156$424
Technetium tc-99m tetrofosmin, diagnostic, per study dose68$321$500
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician59$49$150
Office visit, established patient (20-29 min)46$68$195
New patient office visit (45-59 min)43$124$360
Nuclear medicine studies of heart muscle at rest and with stress and spect34$325$960
Electrocardiogram (ecg) 2-day continuous with review and report by health care professional24$56$222
Ultrasound of heart, follow-up19$20$253
Hospital follow-up visit, high complexity17$102$220
Ultrasound of heart blood flow, valves and chambers, follow-up15$6$81
Ultrasound of heart with color-depicted blood flow, rate and valve function15$2$52
Evaluation of single, dual, multiple lead or leadless pacemaker system12$15$46
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.0% high complexity
28.2% medium
68.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$8,099
Total received (2018-2024)
Avg $1,157/year across 7 years
Top 29% in FL for cardiovascular disease
35
Companies
473
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,548 (93.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$551 (6.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,367
2023
$1,355
2022
$1,001
2021
$578
2020
$1,141
2019
$1,207
2018
$1,449

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$1,438
Novartis Pharmaceuticals Corporation
$921
Janssen Pharmaceuticals, Inc
$898
SANOFI-AVENTIS U.S. LLC
$800
E.R. Squibb & Sons, L.L.C.
$780
PFIZER INC.
$675
AstraZeneca Pharmaceuticals LP
$489
Abbott Laboratories
$262
Impulse Dynamics (USA) Inc.
$218
Regeneron Healthcare Solutions, Inc.
$197
Kiniksa Pharmaceuticals International, plc
$186
Amarin Pharma Inc.
$122
ATRICURE, INC.
$107
Merck Sharp & Dohme LLC
$107
Medtronic Vascular, Inc.
$105
Esperion Therapeutics, Inc.
$83
Novo Nordisk Inc
$76
Bayer Healthcare Pharmaceuticals Inc.
$74
Bayer HealthCare Pharmaceuticals Inc.
$64
Kestra Medical Technology Services, Inc.
$59
Medtronic, Inc.
$55
Boehringer Ingelheim Pharmaceuticals, Inc.
$42
Lexicon Pharmaceuticals, Inc.
$38
Kiniksa Pharmaceuticals, Ltd.
$35
Edwards Lifesciences Corporation
$33
ARBOR PHARMACEUTICALS, INC.
$31
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$29
Alnylam Pharmaceuticals Inc.
$29
HEARTFLOW, INC.
$26
Noden Pharma USA Inc
$26
Allergan Inc.
$23
Kowa Pharmaceuticals America, Inc.
$19
CVRx, Inc.
$18
Lilly USA, LLC
$18
BOSTON SCIENTIFIC CORPORATION
$16
Top 3 companies account for 40.2% of total payments
Associated products mentioned in payments ›
Allure Quadra RF CRT Pacemaker · Arcalyst · Assure WCD · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CRT-Ds · Claria MRI · Corlanor · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · Edarbi · Edarbyclor · FARXIGA · FFRct · Inpefa · JARDIANCE · Kerendia · LEQVIO · LifeVest · Livalo · MICRA · MITRACLIP · MOUNJARO · MULTAQ · NEXLETOL · ONPATTRO · OPTIMIZER · Optimizer · Ozempic · PAXLOVID · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Quadra Assura CRT Defibrillator · RYBELSUS · Repatha · Rybelsus · TEKTURNA · VERQUVO · VYNDAQEL · Vascepa · WAINUA · WATCHMAN · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $174 per 100 Medicare services performed
Looking for a cardiovascular disease in Miami?
Compare cardiovascular diseases in the Miami area by procedure volume, costs, and industry payment transparency.
Browse cardiovascular diseases nearby

Geographic Context

Cardiovascular Diseases within 10 mi
306
Per 100K population
11.4
County median income
$68,694
Nearest hospital
SOUTH MIAMI HOSPITAL
2.4 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Polanco is a clinical cardiology specialist, with above-average Medicare volume (top 23% in FL), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Polanco experienced with injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)?
Based on Medicare claims data, Dr. Polanco performed 1,200 injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Polanco receive payments from pharmaceutical companies?
Yes. Dr. Polanco received a total of $8,099 from 35 companies across 473 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Polanco's costs compare to other cardiovascular diseases in Miami?
Dr. Polanco's average Medicare payment per service is $37. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Polanco) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →